GCM
CELG

Geneva Capital Management’s Celgene Corp CELG Stock Holding History

Geneva Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.86M Buy
19,635
+433
+2% +$39.1K 0.05% 105
2014
Q2 		$1.65M Buy
19,202
+320
+2% +$24.3K 0.04% 107
2014
Q1 		$1.32M Sell
18,882
-3,310
-15% -$262K 0.03% 119
2013
Q4 		$1.88M Buy
22,192
+120
+0.5% +$9.49K 0.04% 104
2013
Q3 		$1.7M Sell
22,072
-2,072
-9% -$145K 0.04% 105
2013
Q2 		$1.41M Buy
+24,144
New +$1.45M 0.03% 108

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Geneva Capital Management's CELG Position: Q3 2014 in Review

Geneva Capital Management increased its Celgene Corp (CELG) stake by 2.3% in Q3 2014, buying an estimated $39.1K and bringing the position to 19,635 shares worth $1.86M. The position accounts for 0.05% of the portfolio, ranked #105.

Geneva Capital Management first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.88M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Geneva Capital Management held 19,635 shares of Celgene Corp worth $1.86M as of Q3 2014.
  • Geneva Capital Management bought 433 Celgene Corp shares in Q3 2014, an estimated $39.1K.
  • Celgene Corp made up 0.05% of Geneva Capital Management's portfolio in Q3 2014, its #105 holding.
  • Geneva Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • Geneva Capital Management's Celgene Corp position peaked at $1.88M in Q4 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Geneva Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.